08/04/2019 13:15:00

Recent Analysis Shows Acuity Brands, VICI Properties, Interface, Cytosorbents, Digimarc, and USA Technologies Market Influences — Renewed Outlook, Key Drivers of Growth

NEW YORK, April 08, 2019 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Acuity Brands Inc (NYSE:AYI), VICI Properties Inc. (NYSE:VICI), Interface, Inc. (NASDAQ:TILE), Cytosorbents Corporation (NASDAQ:CTSO), Digimarc Corporation (NASDAQ:DMRC), and USA Technologies, Inc. (NASDAQ:USAT), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

AYI DOWNLOAD: https://MarketSourceResearch.com/register/?so=AYI

VICI DOWNLOAD: https://MarketSourceResearch.com/register/?so=VICI

TILE DOWNLOAD: https://MarketSourceResearch.com/register/?so=TILE

CTSO DOWNLOAD: https://MarketSourceResearch.com/register/?so=CTSO

DMRC DOWNLOAD: https://MarketSourceResearch.com/register/?so=DMRC

USAT DOWNLOAD: https://MarketSourceResearch.com/register/?so=USAT

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Market Source Research, available for free download at the links above, examine Acuity Brands Inc (NYSE:AYI), VICI Properties Inc. (NYSE:VICI), Interface, Inc. (NASDAQ:TILE), Cytosorbents Corporation (NASDAQ:CTSO), Digimarc Corporation (NASDAQ:DMRC), and USA Technologies, Inc. (NASDAQ:USAT) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

Important Notice:

the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

ACUITY BRANDS INC (AYI) REPORT OVERVIEW

Acuity Brands' Recent Financial Performance

For the three months ended February 28th, 2019 vs February 28th, 2018, Acuity Brands reported revenue of $854.40MM vs $832.10MM (up 2.68%) and analysts estimated basic earnings per share $1.68 vs $2.34 (down 28.21%). For the twelve months ended August 31st, 2018 vs August 31st, 2017, Acuity Brands reported revenue of $3,680.10MM vs $3,505.10MM (up 4.99%) and analysts estimated basic earnings per share $8.54 vs $7.46 (up 14.48%). Analysts expect earnings to be released on July 2nd, 2019. The report will be for the fiscal period ending May 31st, 2019. The reported EPS for the same quarter last year was $2.23. The estimated EPS forecast for the next fiscal year is $8.91 and is expected to report on October 2nd, 2019.

To read the full Acuity Brands Inc (AYI) report, download it here: https://MarketSourceResearch.com/register/?so=AYI

-----------------------------------------

VICI PROPERTIES INC. (VICI) REPORT OVERVIEW

VICI Properties' Recent Financial Performance

For the twelve months ended December 31st, 2018 vs December 31st, 2017, VICI Properties reported revenue of $897.98MM vs $187.61MM (up 378.64%) and analysts estimated basic earnings per share $1.43 vs $0.19 (up 652.63%). Analysts expect earnings to be released on May 2nd, 2019. The report will be for the fiscal period ending March 31st, 2019. Reported EPS for the same quarter last year was $0.36. The estimated EPS forecast for the next fiscal year is $1.66 and is expected to report on February 13th, 2020.

To read the full VICI Properties Inc. (VICI) report, download it here: https://MarketSourceResearch.com/register/?so=VICI

-----------------------------------------

INTERFACE, INC. (TILE) REPORT OVERVIEW

Interface's Recent Financial Performance

For the three months ended December 31st, 2018 vs December 31st, 2017, Interface reported revenue of $337.06MM vs $266.21MM (up 26.61%) and analysts estimated basic earnings per share $0.10 vs $0.08 (up 25.00%). For the twelve months ended December 31st, 2018 vs December 31st, 2017, Interface reported revenue of $1,179.57MM vs $996.44MM (up 18.38%) and analysts estimated basic earnings per share $0.84 vs $0.86 (down 2.33%). Analysts expect earnings to be released on April 24th, 2019. The report will be for the fiscal period ending March 31st, 2019. Reported EPS for the same quarter last year was $0.25. The estimated EPS forecast for the next fiscal year is $1.95 and is expected to report on February 18th, 2020.

To read the full Interface, Inc. (TILE) report, download it here: https://MarketSourceResearch.com/register/?so=TILE

-----------------------------------------

CYTOSORBENTS CORPORATION (CTSO) REPORT OVERVIEW

Cytosorbents' Recent Financial Performance

For the three months ended December 31st, 2018 vs December 31st, 2017, Cytosorbents reported revenue of $6.08MM vs $4.65MM (up 30.86%) and basic earnings per share -$0.17 vs -$0.13. For the twelve months ended December 31st, 2018 vs December 31st, 2017, Cytosorbents reported revenue of $22.50MM vs $15.15MM (up 48.53%) and analysts estimated basic earnings per share -$0.56 vs -$0.32. Analysts expect earnings to be released on May 14th, 2019. The report will be for the fiscal period ending March 31st, 2019. The reported EPS for the same quarter last year was -$0.10. The estimated EPS forecast for the next fiscal year is -$0.31 and is expected to report on March 5th, 2020.

To read the full Cytosorbents Corporation (CTSO) report, download it here: https://MarketSourceResearch.com/register/?so=CTSO

-----------------------------------------

DIGIMARC CORPORATION (DMRC) REPORT OVERVIEW

Digimarc's Recent Financial Performance

For the three months ended December 31st, 2018 vs December 31st, 2017, Digimarc reported revenue of $5.23MM vs $4.86MM (up 7.60%) and analysts estimated basic earnings per share -$0.70 vs -$0.76. For the twelve months ended December 31st, 2018 vs December 31st, 2017, Digimarc reported revenue of $21.19MM vs $25.21MM (down 15.95%) and analysts estimated basic earnings per share -$2.86 vs -$2.44. Analysts expect earnings to be released on April 24th, 2019. The report will be for the fiscal period ending March 31st, 2019. The reported EPS for the same quarter last year was -$0.72.

To read the full Digimarc Corporation (DMRC) report, download it here: https://MarketSourceResearch.com/register/?so=DMRC

-----------------------------------------

USA TECHNOLOGIES, INC. (USAT) REPORT OVERVIEW

USA Technologies' Recent Financial Performance

For the three months ended March 31st, 2018 vs March 31st, 2017, USA Technologies reported revenue of $35.83MM vs $26.46MM (up 35.42%) and analysts estimated basic earnings per share $0.02 vs $0.00. For the twelve months ended June 30th, 2017 vs June 30th, 2016, USA Technologies reported revenue of $104.09MM vs $77.41MM (up 34.47%) and analysts estimated basic earnings per share -$0.06 vs -$0.21. Analysts expect earnings to be released on May 14th, 2019. The report will be for the fiscal period ending March 31st, 2019. The reported EPS for the same quarter last year was $0.04.

To read the full USA Technologies, Inc. (USAT) report, download it here: https://MarketSourceResearch.com/register/?so=USAT

-----------------------------------------

ABOUT MARKET SOURCE RESEARCH

Market Source Research delivers the key research reports that helps serious investors, registered brokers, professional traders, and personal investment advisers find reliable information in today's markets. Market Source Research's team is comprised of financial professionals, many of which hold Chartered Financial Analyst® (CFA®) designations and FINRA® BrokerCheck® certifications. Whether identifying emerging trends, or discovering new opportunity, the team at Market Source Research is dedicated to providing accurate, informative, and objective content that's ahead of the curve. With insights on individual companies as well as sectors, readers get the industry's best available combination of big-picture perspective as well as granular detail.

REGISTERED MEMBER STATUS

Market Source Research's oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Market Source Research's roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Market Source Research have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Market Source Research's Compliance department by Phone, at +1 (704) 343-6361, or by E-mail at compliance@MarketSourceResearch.com.

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Market Source Research, Market Source Research members, and/or Market Source Research affiliates are not responsible for any gains or losses that result from the opinions expressed. Market Source Research makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Market Source Research has not been compensated for the publication of this press release by any of the above mentioned companies. Market Source Research is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact:

Jim Patterson, Media Department

Office: +1 (704) 343-6361

E-mail: media@MarketSourceResearch.com

© 2019 Market Source Research. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@MarketSourceResearch.com.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.

Del

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
18 May
OMXC25
Et stort flertal af klimaforskerne mener klimaændringerne er menneskeskabte. Dvs. de uddannede perso..
28
15 May
DANSKE
Meget interessant refleksion skrevet af Maui. Det kan vores medier godt lære lidt af. Det der kommer..
25
15 May
PNDORA
I gaar aftes sad jeg og kiggede lidt naermere paa guidance fra Pandora for FY2019, som de meldte ud ..
22
14 May
E:THIN
Så sidder jeg her og glor på mit depot. Thinfilm falder ekstra meget i øjnene med afkast på minus 96..
20
17 May
VELO
Hej Alle,   Har siddet og kigget på regnskabet, for at finde ud af hvordan 2019 ender. Umiddelbart e..
18
18 May
VWS
Ditlev.. Havde store ambitioner, og store armbevægelser .. Ikke alt gik godt.. Men finanskrisen kan..
17
18 May
OMXC25
Når man begynder at bruge børn som Greta Thunberg for at fremhæve et budskab ringer advarselsklokker..
17
15 May
DANSKE
Apropos skribent 6212.. Og Danske Bank..Ja så må man lade vedkommende at han/hun fik ret. Han anbefa..
16
14 May
DANSKE
Sjovt at der ikke er nogen kritik af SKATs manglende kontrolindsats i forbindelse med momssvindlen, ..
16
18 May
ZEAL
Nedenfor er det samlet udskift af Q1 telefonkonferencen for Zealand Pharma.    Jeg har først trukket..
15

#

EuroInvestor: In Focus
#

#

EuroInvestor: In Focus
#

#

EuroInvestor: In Focus
#

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
FDA and Infant Bacterial Therapeutics agree on the design of Phase III study
2
New Report Shows CRC Screening Rates Increased When a Medically Underserved Population is Offered Epi proColon® Blood Test
3
PRF: Consolidated Unaudited Interim Report of AS PRFoods for 3rd quarter and 9 months of 2018/2019 financial year
4
Eimskip: Letter from Gylfi Sigfússon´s attorney concerning District Prosecutor‘s investigation
5
Trilogy International Partners Inc. Announces New Zealand CEO Transition

Latest news


Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
20 May 2019 12:20:42
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20190514.2 - EUROWEB2 - 2019-05-20 13:20:42 - 2019-05-20 12:20:42 - 1000 - Website: OKAY